PDF Chronic kidney disease
In August 2021, the National Institute for Health and CareExcellence(NICE)publishedNG203,2anupdated and combined version of three guidelines : "chronic kidney disease in adults: assessment and management," "chronic kidney disease (stage 4 or 5): management of hyperphosphataemia," and "chronic kidney disease: managing anaemia." The guideline was extended to cover the assessment and ...

This is an updated, combined version of three guidelines : "chronic kidney disease in adults: assessment and management", "chronic kidney disease (stage 4 or 5): management of hyperphosphataemia", and "chronic kidney disease: managing anaemia" and was also extended to cover children and young people (CAYP).
Chronic kidney disease

Key NICE recommendations on diagnosis This summary covers chronic kidney disease (CKD) in adults. Offer testing for CKD using eGFRcreatinine (glomerular filtration rate [GFR] estimated using serum creatinine) and albumin:creatinine ratio (ACR) to adults with any of the following risk factors: Diabetes Hypertension Previous episode of acute kidney injury (AKI) Monitor people for the development ...
As kidney dysfunction advances, the mortality risk increases, as does risk of cardiovascular disease, and some comorbidities (such as diabetes and hypertension) become more severe. Most adults with CKD are managed primarily in primary care, but they may need more input from secondary care as the disease progresses.

PDF Guidelines for the Management of Chronic Kidney Disease (CKD) for Adults
Finerenone for treating chronic kidney disease (CKD) (stage 3 and 4 with albuminuria) associated with type 2 diabetes in adults: Prescribing Information Sheet. March 2024.
The Renal National Service Framework (NSF), and the subsequent NICE Clinical Practice Guideline for early identification and management of adults with chronic kidney disease (CKD) in primary and secondary care (CG73), served to emphasise the change in focus in renal medicine from treatment of established kidney disease to earlier identification and prevention of kidney disease.

Chronic kidney disease
Chronic kidney disease Detailed summary of NICE NG203: eGFR/ACR staging, SGLT2i criteria, and referral thresholds.
Overview This Medscape summary covers NICE's guidance on the assessment and management of CKD, and includes recommendations on CKD classification, investigations, monitoring, risk assessment, pharmacotherapy, and complications. View the related Medscape summary, Chronic Kidney Disease and Anaemia, for recommendations on: diagnosing and assessing anaemia; managing anaemia; assessing and ...

Key Details About Kidney Failure Nice Guidelines
This guideline covers care and treatment for people with, or at risk of, chronic kidney disease (CKD). It aims to prevent or delay the progression, and reduce the risk of complications and cardiovascular disease.





This guideline covers care and treatment for people with, or at risk of, chronic kidney disease (CKD). It aims to prevent or delay the progression, and reduce the risk of complications and cardiovascular disease. It also covers managing anaemia and hyperphosphataemia associated with CKD